- Home
- QURE vs IQ Comparison
QURE vs IQ Comparison
Compare QURE & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | IQ |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | Netherlands | China |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2013 | 2017 |
Fundamental Metrics
Financial Performance| Metric | QURE | IQ |
|---|---|---|
| Price | $26.64 | $1.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | ★ $45.00 | $2.91 |
| AVG Volume (30 Days) | 1.6M | ★ 9.8M |
| Earning Date | 05-05-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | $0.28 |
| Revenue Next Year | $200.43 | $3.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $1.07 |
| 52 Week High | $71.50 | $2.76 |
Technical Indicators
Market Signals| Indicator | QURE | IQ |
|---|---|---|
| Relative Strength Index (RSI) | 76.81 | 42.92 |
| Support Level | $22.59 | $1.20 |
| Resistance Level | $28.63 | $1.47 |
| Average True Range (ATR) | 1.80 | 0.06 |
| MACD | 0.89 | 0.01 |
| Stochastic Oscillator | 80.84 | 38.24 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.